These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19795463)

  • 1. Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells.
    Kawada M; Inoue H; Ohba S; Masuda T; Momose I; Ikeda D
    Int J Cancer; 2010 Feb; 126(4):810-8. PubMed ID: 19795463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions.
    Kawada M; Inoue H; Usami I; Ikeda D
    Cancer Sci; 2009 Jan; 100(1):150-7. PubMed ID: 19018764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.
    Kawada M; Inoue H; Masuda T; Ikeda D
    Cancer Res; 2006 Apr; 66(8):4419-25. PubMed ID: 16618768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
    Kawada M; Inoue H; Arakawa M; Ikeda D
    Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cells.
    Ohishi T; Abe H; Sakashita C; Saqib U; Baig MS; Ohba SI; Inoue H; Watanabe T; Shibasaki M; Kawada M
    Int J Cancer; 2020 Jun; 146(12):3474-3484. PubMed ID: 32144767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells.
    Kawada M; Yoshimoto Y; Minamiguchi K; Kumagai H; Someno T; Masuda T; Ishizuka M; Ikeda D
    Anticancer Res; 2004; 24(3a):1561-8. PubMed ID: 15274323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells.
    Liu X; Allen JD; Arnold JT; Blackman MR
    Carcinogenesis; 2008 Apr; 29(4):816-23. PubMed ID: 18283040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.
    Hori Y; Ishii K; Kanda H; Iwamoto Y; Nishikawa K; Soga N; Kise H; Arima K; Sugimura Y
    Cancer Prev Res (Phila); 2011 Jan; 4(1):87-96. PubMed ID: 21205739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells.
    Uemura H; Ishiguro H; Nagashima Y; Sasaki T; Nakaigawa N; Hasumi H; Kato S; Kubota Y
    Mol Cancer Ther; 2005 Nov; 4(11):1699-709. PubMed ID: 16275991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells.
    Kawada M; Momose I; Someno T; Tsujiuchi G; Ikeda D
    J Antibiot (Tokyo); 2009 May; 62(5):243-6. PubMed ID: 19282876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells.
    Ishii K; Mizokami A; Tsunoda T; Iguchi K; Kato M; Hori Y; Arima K; Namiki M; Sugimura Y
    J Cell Biochem; 2011 Dec; 112(12):3604-11. PubMed ID: 21809373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
    Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
    Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716.
    Kawada M; Someno T; Inoue H; Ohba S; Masuda T; Kato T; Ikeda D
    J Antibiot (Tokyo); 2010 Jun; 63(6):319-23. PubMed ID: 20431616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors.
    Lamharzi N; Schally AV; Koppán M; Groot K
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8864-8. PubMed ID: 9671770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.
    King KJ; Nicholson HD; Assinder SJ
    Prostate; 2006 Jan; 66(1):105-14. PubMed ID: 16114065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction.
    Nishimura K; Kitamura M; Miura H; Nonomura N; Takada S; Takahara S; Matsumoto K; Nakamura T; Matsumiya K
    Prostate; 1999 Nov; 41(3):145-53. PubMed ID: 10517872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.